Protocol for purification of cells in their native state using reversible aptamer-antidote pairs

Gray, 2020, Aptamers as Reversible Sorting Ligands for Preparation of Cells in Their Native State, Cell Chem. Biol., 27, 232, 10.1016/j.chembiol.2019.12.004 Conrad, 1996, In vitro selection of nucleic acid aptamers that bind proteins, Methods Enzymol., 267, 336, 10.1016/S0076-6879(96)67022-0 Tuerk, 1990, Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase, Science, 249, 505, 10.1126/science.2200121 Dollins, 2008, Aptamers in immunotherapy, Hum. Gene Ther., 19, 443, 10.1089/hum.2008.045 Nimjee, 2017, Aptamers as therapeutics, Annu. Rev. Pharmacol. Toxicol., 57, 61, 10.1146/annurev-pharmtox-010716-104558 Zhou, 2015, Cell-specific RNA aptamer against human CCR5 specifically targets HIV-1 susceptible cells and inhibits HIV-1 infectivity, Chem. Biol., 22, 379, 10.1016/j.chembiol.2015.01.005 Long, 2008, Crystal structure of an RNA aptamer bound to thrombin, RNA, 14, 2504, 10.1261/rna.1239308 Gunaratne, 2018, Combination of aptamer and drug for reversible anticoagulation in cardiopulmonary bypass, Nat. Biotechnol., 36, 606, 10.1038/nbt.4153 Nimjee, 2006, A novel antidote-controlled anticoagulant reduces thrombin generation and inflammation and improves cardiac function in cardiopulmonary bypass surgery, Mol. Ther., 14, 408, 10.1016/j.ymthe.2006.04.006 Zhou, 2014, Cell-type-specific, aptamer-functionalized agents for targeted disease therapy, Mol. Ther. Nucleic Acids, 3, e169, 10.1038/mtna.2014.21 Yan, 2014, Cell internalization SELEX: in vitro selection for molecules that internalize into cells, Methods Mol. Biol., 1103, 241, 10.1007/978-1-62703-730-3_18 Pratico, 2013, Identification and characterization of an agonistic aptamer against the T cell costimulatory receptor, OX40, Nucleic Acid Ther., 23, 35, 10.1089/nat.2012.0388 Rusconi, 2002, RNA aptamers as reversible antagonists of coagulation factor IXa, Nature, 419, 90, 10.1038/nature00963 Nimjee, 2019, Preclinical development of a vWF aptamer to limit thrombosis and engender arterial recanalization of occluded vessels, Mol. Ther., 27, 1228, 10.1016/j.ymthe.2019.03.016 Zhou, 2009, A hybrid DNA aptamer-dendrimer nanomaterial for targeted cell labeling, Macromol. Biosci., 9, 831, 10.1002/mabi.200900046 LLC, 2023 Kelly, 2021, A comparative analysis of cell surface targeting aptamers, Nat. Commun., 12, 6275, 10.1038/s41467-021-26463-w Magalhães, 2012, A general RNA motif for cellular transfection, Mol. Ther., 20, 616, 10.1038/mt.2011.277 Chen, 2003, Inhibition of heregulin signaling by an aptamer that preferentially binds to the oligomeric form of human epidermal growth factor receptor-3, Proc. Natl. Acad. Sci. USA, 100, 9226, 10.1073/pnas.1332660100 Li, 2011, Inhibition of cell proliferation by an anti-EGFR aptamer, PLoS One, 6, e20299, 10.1371/journal.pone.0020299 Powell Gray, 2018, Tunable cytotoxic aptamer-drug conjugates for the treatment of prostate cancer, Proc. Natl. Acad. Sci. USA, 115, 4761, 10.1073/pnas.1717705115